[EFFECT] Nasus Pharma Ltd SEC Filing

(Neutral)

(Neutral)

Form Type

EFFECT

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Available on EDGAR 08/21/2026 - 06:10 AM Accepted by SEC EDGAR 08/21/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 20, 2026

Accession Number:

0001493152-26-039052

Submission Type:

POS AM

Source: View Original Filing on SEC EDGAR